Shares of Vaxcyte, a US clinical-stage vaccine innovation company, rocketed as much as 90% in pre-market activity today ...

An Expert View from Joel Stanley, CEO of AJNA BioSciences, a company developing botanical medicines from cannabis and ...

Danish pharma major Novo has reported results from REVEAL-1, which it describes as the largest UK real-world study of Wegovy ...

Jiangsu Nhwa Pharmaceutical, the Chinese CNS-focused pharma company, has granted newly-formed US biotech Somnivera exclusive ...

Chinese drugmaker Hansoh Pharmaceutical (HKEX: 3692) plans to resubmit its lung cancer drug Aumseqa (aumolertinib) for ...

Patients taking part in a clinical trial may be able to have blood drawn at home, speak to the study doctor by video and ...

Swedish immuno-oncology firm Alligator Bioscience has announced the appointment of Johan Giléus as Alligator’s new chief ...

A privately held New York biotech, formerly Kallyope, that rebranded in October 2026 to focus on migraine, raised $94 million ...

Australia’s CSL Limited and Swiss clinical-stage biotech Alentis Therapeutics today announced an exclusive global ...

BioMarin Pharmaceutical announced new data evaluating the efficacy and safety of Pombiliti (cipaglucosidase alfa-atga) + ...

Safety notices, revised product information and recalls accounted for much of the regulatory activity affecting human medicines between September 26 and October 5, 2026. Authorities in the USA, Europe ...

When a treatment moves from a clinical trial to the real-world post-marketing environment, the increased number of variables can lead to new or rare adverse events. Post-marketing pharmacovigilance ...